- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/737 - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
Patent holdings for IPC class A61K 31/737
Total number of patents in this class: 913
10-year publication summary
72
|
75
|
63
|
79
|
78
|
98
|
72
|
69
|
64
|
21
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
TX Medic AB | 42 |
30 |
Paradigm Biopharmaceuticals Ltd. | 29 |
22 |
Fidia Farmaceutici S.p.A. | 643 |
20 |
Sofar Swiss SA | 44 |
11 |
Institut Francais de Recherche pour L'exploitation de La Mer (ifremer) | 52 |
10 |
Organes Tissus Regeneration Reparation Remplacement - Otr3 | 12 |
10 |
Seikagaku Corporation | 189 |
10 |
ARC Medical Devices, Inc. | 15 |
9 |
Bioiberica, S.A. | 42 |
9 |
GNOSIS S.p.A. | 112 |
9 |
Maruho Co., Ltd. | 92 |
8 |
The Brigham and Women's Hospital, Inc. | 2166 |
7 |
Oji Holdings Corporation | 716 |
7 |
Paradigm Health Sciences Pty Ltd | 7 |
7 |
Logick Energetics B.V. | 9 |
7 |
Centre National de La Recherche Scientifique | 10311 |
6 |
Altergon S.A. | 137 |
6 |
BioAtlantis Ltd | 56 |
6 |
Pierre Fabre Dermo-Cosmetique | 364 |
6 |
Glycomira Therapeutics, Inc. | 10 |
6 |
Other owners | 707 |